Southern Eye Associates

Recent papers from Southern Eye Associates

1. The Minority Ophthalmology Mentoring Program: A Model for Increasing Diversity in Surgical SpecialtiesAcademic Medicine · 2026
2. Cutaneous laser treatment of port-wine stains and its impact on ocular manifestations in Sturge–Weber syndromeFrontiers in Ophthalmology · 2026
3. Statewide Access to Ophthalmologic Care in South Carolina: A Cross-Sectional Evaluation of Appointment AvailabilityAJO International · 2026
4. Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 StudyClinical ophthalmology · 2026
5. A Clinical Study Evaluating How Delefilcon A Contact Lenses Perform in Satisfied Senofilcon A Contact Lens WearersThe Open Ophthalmology Journal · 2025
6. Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysisJournal of Managed Care & Specialty Pharmacy · 2022
7. Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative TrialJournal of Glaucoma · 2022
8. Rotational Stability of the Clareon Monofocal Aspheric Hydrophobic Acrylic Intraocular Lens 6 Months After ImplantationClinical ophthalmology · 2022
9. Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysisJournal of Managed Care & Specialty Pharmacy · 2021
10. Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large SampleClinical ophthalmology · 2021
11. Twelve-Month Outcomes of Stand-Alone Excisional Goniotomy in Mild to Severe GlaucomaClinical ophthalmology · 2020
12. Management and Outcomes for Neovascular Age-Related Macular DegenerationOphthalmology · 2020
13. The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular EdemaOphthalmology and Therapy · 2018
14. Patient Outcomes Following Micropulse Transscleral Cyclophotocoagulation: Intermediate-term ResultsJournal of Glaucoma · 2018
15. Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical PracticeAmerican Journal of Ophthalmology · 2018
16. Malpractice Litigation in Cornea and Refractive Surgery: A Review of the WestLaw DatabaseCornea · 2018
17. Malpractice Litigation in Ocular OncologyOcular Oncology and Pathology · 2017
18. 4-Acetoxyphenol Prevents RPE Oxidative Stress–Induced Necrosis by Functioning as an NRF2 StabilizerInvestigative Ophthalmology & Visual Science · 2015
19. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME studyClinical ophthalmology · 2015
20. Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edemaClinical ophthalmology · 2014